Bell’s Palsy Clinical Practice Guidelines (SFORL, 2020)

French Society of ENT (SFORL)

This is a quick summary of the guidelines without analysis or commentary. For more information, go directly to the guidelines by clicking the link in the reference.

July 29, 2020

In July 2020, the French Society of ENT (SFORL) published clinical practice guidelines on the management of acute Bell’s Palsy.[1]

The SFORL recommendations for management of acute Bell’s palsy include the following:

A thorough ENT and neurologic clinical examination is recommended in all patients who present with peripheral facial palsy to confirm diagnosis of Bell's palsy.

Within the first month of presentation, an MRI with gadolinium enhancement should be performed to explore the entire course of the facial nerve, if possible.

Electroneuromyography (ENMG) should be performed to assess the prognosis of recovery for the patient with Bell’s palsy.

In cases in which Bell's palsy is confirmed, corticosteroid therapy should be instituted as early as possible, ideally within 72 hours, at a dose of 1mg/kg/day for 7-10 days.

Antiviral therapy should be used along with steroids in patients who have severe and early onset of Bell’s palsy and in patients with Ramsay-Hunt syndrome. Isolated antiviral therapy is not recommended.

There is no evidence to suggest that surgical facial nerve decompression provides benefit.

For more information, please go to Bell Palsy.

For more Clinical Practice Guidelines, please go to Guidelines.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: